Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
US Physical Therapy
USPH
$1.22B
| $1.47M | ﹤0.01% |
20,315
-7,217
| -26% | -$606K |
|
|
SNDK
2827
PUT
Sandisk
SNDK
$223B
| $1.47M | ﹤0.01% |
+30,822
| New | +$1.53M |
|
2828
Safety Insurance
SAFT
$1.52B
| $1.47M | ﹤0.01% |
18,603
-7,248
| -28% | -$567K |
|
2829
Liberty Live Group Series A
LLYVA
$9.59B
| $1.47M | ﹤0.01% |
21,822
-389
| -2% | -$27.1K |
|
2830
Leggett & Platt
LEG
$1.29B
| $1.47M | ﹤0.01% |
185,496
+84,043
| +83% | +$797K |
|
2831
STAAR Surgical
STAA
$1.26B
| $1.47M | ﹤0.01% |
83,136
-13,633
| -14% | -$273K |
|
2832
Full Truck Alliance
YMM
$9.2B
| $1.46M | ﹤0.01% |
+114,074
| New | +$1.37M |
|
2833
Vista Energy
VIST
$7.31B
| $1.46M | ﹤0.01% |
31,250
+19,920
| +176% | +$1.03M |
|
2834
Helios Technologies
HLIO
$2.66B
| $1.45M | ﹤0.01% |
45,303
-16,105
| -26% | -$649K |
|
2835
Appian
APPN
$2.49B
| $1.45M | ﹤0.01% |
50,432
-24,591
| -33% | -$805K |
|
2836
Brookfield Renewable
BEPC
$6.5B
| $1.45M | ﹤0.01% |
51,908
-12,216
| -19% | -$335K |
|
2837
Xometry
XMTR
$5.34B
| $1.45M | ﹤0.01% |
58,039
-18,646
| -24% | -$586K |
|
2838
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $1.45M | ﹤0.01% |
1,204
+696
| +137% | +$839K |
|
|
AAMI
2839
Acadian Asset Management
AAMI
$3.31B
| $1.44M | ﹤0.01% |
55,871
-7,073
| -11% | -$178K |
|
2840
CALL
Ultragenyx Pharmaceutical
RARE
$2.6B
| $1.44M | ﹤0.01% |
+39,900
| New | +$1.66M |
|
2841
PUT
Cummins
CMI
$87.8B
| $1.44M | ﹤0.01% |
4,600
| – | – |
|
2842
Aurinia Pharmaceuticals
AUPH
$2.02B
| $1.44M | ﹤0.01% |
178,533
-65,415
| -27% | -$530K |
|
|
BDN
2843
Brandywine Realty Trust
BDN
$541M
| $1.44M | ﹤0.01% |
321,771
-106,076
| -25% | -$525K |
|
2844
Arcus Biosciences
RCUS
$3.67B
| $1.43M | ﹤0.01% |
182,731
+69,693
| +62% | +$808K |
|
2845
Globalstar
GSAT
$10.8B
| $1.43M | ﹤0.01% |
68,736
-23,045
| -25% | -$558K |
|
2846
Unitil
UTL
$992M
| $1.43M | ﹤0.01% |
24,841
-8,399
| -25% | -$462K |
|
2847
Harmonic Inc
HLIT
$1.42B
| $1.43M | ﹤0.01% |
149,384
-53,916
| -27% | -$594K |
|
2848
Rush Enterprises Class B
RUSHB
$9.18B
| $1.43M | ﹤0.01% |
25,341
-4,313
| -15% | -$240K |
|
2849
EverQuote
EVER
$867M
| $1.43M | ﹤0.01% |
54,620
-12,685
| -19% | -$290K |
|
2850
CALL
TripAdvisor
TRIP
$1.26B
| $1.42M | ﹤0.01% |
+100,000
| New | +$1.57M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.